0001209191-16-149330.txt : 20161110 0001209191-16-149330.hdr.sgml : 20161110 20161110161436 ACCESSION NUMBER: 0001209191-16-149330 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161109 FILED AS OF DATE: 20161110 DATE AS OF CHANGE: 20161110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Friedman Michael A CENTRAL INDEX KEY: 0001298083 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 161988200 MAIL ADDRESS: STREET 1: 28903 NORTH AVENUE PAINE CITY: VALENCIA STATE: CA ZIP: 91355 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-11-09 0 0000816284 CELGENE CORP /DE/ CELG 0001298083 Friedman Michael A C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 1 0 0 0 Common Stock 2016-11-09 4 M 0 18600 31.80 A 18600 D Common Stock 2016-11-09 4 S 0 18600 116.10 D 0 D Common Stock 14199 I Family Trust Stock Option (right to buy) 31.80 2016-11-09 4 M 0 18600 D 2022-06-13 Common Stock 18600 0 D The shares were sold by the reporting person pursuant to a Rule 10b5-1 plan. The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. The option was fully exercisable. The option was issued pursuant to the Company's 2008 Stock Incentive Plan (as amended and restated as of April 15, 2015). /s/Mark J. Alles _________________________________________________________ Mark J. Alles, Attorney-in-Fact 2016-11-09